Sample | Title | Value | Rank |
GSM1256964 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 1 | 263.188 | 88 |
GSM1256965 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 2 | 209.01 | 86 |
GSM1256966 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 3 | 192.477 | 85 |
GSM1256967 | SLE-patients; Group 2: CD16neg, inflammatory monocytes; active SLE 4 | 171.111 | 84 |
GSM1256980 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 54 before YFV | 173.26 | 83 |
GSM1256984 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 54 seven days after YFV | 200.624 | 85 |
GSM1256981 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 55 before YFV | 215.716 | 86 |
GSM1256985 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 55 seven days after YFV | 225.384 | 86 |
GSM1256982 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 56 before YFV | 206.416 | 85 |
GSM1256986 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 56 seven days after YFV | 262.157 | 88 |
GSM1256983 | Yellow fever vaccinated NDs; Group 6: CD16neg, inflammatory monocytes; ND 57 before YFV | 237.05 | 87 |
GSM1256987 | Yellow fever vaccinated NDs; Group 7: CD16neg, inflammatory monocytes; ND 57 seven days after YFV | 235.449 | 87 |